Get started
Author

Jacobien R. Hilberink

Observed names: Hilberink, J.R., J. R. Hilberink, Jacobien Hilberink, Jacobien R Hilberink
ORCID: 0000-0003-3726-8935
Observed ORCID: 0000-0003-3726-8935
OpenAlex ID: A5091745247
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
2023 · Isabel Weinhäuser, Diego A. Pereira-Martins, et al. · Science Advances · 76
PDF
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
2021 · Se young Han, Krzysztof Mrózek, et al. · Blood Advances · 48
PDF
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
2022 · Keli Lima, Diego Antonio Pereira-Martins, et al. · Blood Cancer Journal · 28
PDF
Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐ CBF it)
2018 · Celalettin Ustun, Elizabeth Morgan, et al. · Cancer Medicine · 26
PDF
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability
2025 · Diego A. Pereira-Martins, Isabel Weinhäuser, et al. · Signal Transduction and Targeted Therapy · 19
PDF
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients
2019 · Jacobien Hilberink, Carin Hazenberg, et al. · Leukemia Research · 18
PDF
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional Chemotherapy
2020 · Jacobien R. Hilberink, Linde M. Morsink, et al. · Transplantation and Cellular Therapy · 13
PDF
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation
2021 · Marjan Cruijsen, Jacobien R. Hilberink, et al. · Bone Marrow Transplantation · 10
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
2024 · Cesar Alexander Ortiz Rojas, Diego Antonio Pereira‐Martins, et al. · British Journal of Haematology · 7
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
2023 · Jacobien R. Hilberink, Isabelle A. van Zeventer, et al. · Blood Cancer Journal · 5
PDF
Functional Drug Screen Identifies Thiostrepton, NAMPT Inhibitors and Metformin As Potential Candidates to Target the Macrophage Tumor Microenvironment in Acute Myeloid Leukemia
2022 · Isabel Weinhaeuser, Diego Pereira-Martins, et al. · Blood · 4
Thiostrepton induces cell death of acute myeloid leukemia blasts and the associated macrophage population
2023 · Isabel Weinhäuser, Diego A. Pereira-Martins, et al. · Haematologica · 3
PDF
Treatment of AML in Older Patients
2021 · Jacobien Hilberink, Gerwin Huls · IntechOpen eBooks · 2
Metabolism-Related Features Identify the Combination Metformin Plus NAMPT Inhibitors As a Selective Treatment Strategy in Acute Myeloid Leukemia
2023 · Isabel Weinhaeuser, Diego Pereira-Martins, et al. · Blood · 1
P439: Associating Ex Vivo Drug Sensitivity With Metabolic Status Identifies Effective Combination Strategies in Acute Myeloid Leukemia
2022 · D. A. Pereira-Martins, E. Griessinger, et al. · HemaSphere · 1
Tumor Associated Macrophages Promoted Fatal Patient Derived Acute Promyelocytic Leukemia In Vivo
2021 · Isabel Weinhäuser, Diego A Pereira-Martins, et al. · Blood · 1
Decitabine in the treatment of acute myeloid leukemia
2024 · Jacobien R. Hilberink
P1345: Effect of Decitabine on Macrophage Phenotype and Function in Vitro in the Context of Aml
2023 · Jacobien Hilberink, Isabel Weinhäuser, et al. · HemaSphere
Killing the enemy or making it your ally? The effects of thiostrepton on tumor associated macrophages
2023 · Diego A. Pereira-Martins, Jacobien R. Hilberink, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Targeting PIP4K2 Lipid Kinases through Thz-P1-2 Reveals Vulnerabilities Related to Mitochondrial Homeostasis and Autophagy in Acute Leukemia
2022 · Keli Lima, Diego A Pereira-Martins, et al. · Blood
M2 Macrophages Drive Resistance to Phagocytosis and Improve Mitochondrial Metabolism in Acute Myeloid Leukemia Facilitating Leukemic Transformation and In Vivo Engraftment
2022 · Isabel Weinhaeuser, Diego Pereira-Martins, et al. · Blood
S252: M2-polarized Macrophages Control Leukemic Stem Cell Fate by Promoting Metabolic Reprogramming
2022 · I. Weinhäuser, D. A. Pereira-Martins, et al. · HemaSphere
P437: Survival-based 4-gene Prognostic Index Improves the Eln-risk Classification in Acute Myeloid Leukemia
2022 · C. A. Ortiz Rojas, D. A. Pereira-Martins, et al. · HemaSphere
Works count: 24
Citation count: 261
H-index: 8
I10-index: 8
Year
Topic
Type